HIGHFIELD SURGERY
HOLTDALE APPROACH, LEEDS
CHD 14
The percentage of patients with a history of myocardial infarction (from 1 April 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 11 | 2005 | 13 | 14 | 92.9% | |
| CHD 11 | 2006 | 21 | 24 | 87.5% | |
| CHD 11 | 2007 | 26 | 30 | 86.7% | |
| CHD 11 | 2008 | 32 | 37 | 86.5% | |
| CHD 11 | 2009 | 37 | 44 | 84.1% | |
| CHD 11 | 2010 | 38 | 44 | 86.4% | |
| CHD 11 | 2011 | 40 | 47 | 85.1% | |
| CHD 14 | 2012 | 6 | 6 | 100.0% | |
| CHD 14 | 2013 | 8 | 9 | 88.9% | |
| CHD006 | 2014 | 10 | 10 | 100.0% | |
| CHD006 | 2015 | 11 | 11 | 100.0% |
